34 research outputs found

    Some indication for a missing chiral partner eta_4 around 2 GeV

    Full text link
    The high-lying mesons in the light quark sector previously obtained from the partial wave analysis of the proton-antiproton annihilation in flight at 1.9 - 2.4 GeV region at CERN reveal a very high degree of degeneracy. This degeneracy can be explained as due to an effective restoration of both SU(2)_L * SU(2)_R and U(1)_A symmetries combined with a principal quantum number n + J. In this case there must be chiral partners for the highest spin states in the 2 and 2.3 GeV bands presently missing in the data. Here we reanalyze the Crystal Barrel data and show an indication for existence of the missing 4+4^{-+} state around 2 GeV. This result calls for further experimental search of the missing states both in the proton-antiproton annihilation and in the production reactions.Comment: 4 pp. A fit with the energy-dependent width has been added that agrees with the previous analysis. Accepted by PR

    QCD and strongly coupled gauge theories : challenges and perspectives

    Get PDF
    We highlight the progress, current status, and open challenges of QCD-driven physics, in theory and in experiment. We discuss how the strong interaction is intimately connected to a broad sweep of physical problems, in settings ranging from astrophysics and cosmology to strongly coupled, complex systems in particle and condensed-matter physics, as well as to searches for physics beyond the Standard Model. We also discuss how success in describing the strong interaction impacts other fields, and, in turn, how such subjects can impact studies of the strong interaction. In the course of the work we offer a perspective on the many research streams which flow into and out of QCD, as well as a vision for future developments.Peer reviewe

    NON-VAL30MET-TRANSTHYRETIN AMYLOID CARDIOMYOPATHY. LITERATURE REVIEW AND CLINICAL CASE

    Get PDF
    A literature review presented, with a clinical observation of non-Val30Mettransthyretin amyloid cardiomyopathy. Modern diagnostic and management algorithms discussed
    corecore